Anneken, John H; Cunningham, Jacobi I; Collins, Stuart A et al. (2013) MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. J Neuroimmune Pharmacol 8:58-65
|
Natarajan, Reka; Yamamoto, Bryan K (2011) The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines. Basal Ganglia 1:49-57
|
Northrop, Nicole A; Northrup, Nicole A; Yamamoto, Bryan K (2011) Neuroimmune pharmacology from a neuroscience perspective. J Neuroimmune Pharmacol 6:10-9
|
Yamamoto, Bryan K; Moszczynska, Anna; Gudelsky, Gary A (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 1187:101-21
|
Johnson, Bethann N; Yamamoto, Bryan K (2010) Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. J Pharmacol Exp Ther 335:180-9
|
Johnson, B N; Yamamoto, B K (2009) Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone. Neuroscience 159:1233-43
|
Cunningham, Jacobi I; Raudensky, Jamie; Tonkiss, John et al. (2009) MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behav Neurosci 123:1076-84
|
Gudelsky, Gary A; Yamamoto, Bryan K (2008) Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol Biochem Behav 90:198-207
|
Tata, Despina A; Yamamoto, Bryan K (2008) Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum. Synapse 62:325-36
|
Amato, Jennifer L; Bankson, Michael G; Yamamoto, Bryan K (2007) Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology 32:946-54
|
Showing the most recent 10 out of 17 publications